The addition of lorundrostat, an investigational drug, to the treatment regimen of people with well-treated but uncontrolled and resistant hypertension could be beneficial, new data show. “Lorundrostat effectively lowered blood pressure with an acceptable side effect profile,” said Luke Laffin, MD, a cardiologist at the Cleveland Clinic, Ohio, who presented the results of the ADVANCE-HTN […]
The post ADVANCE-HTN Shows Benefit of Lorundrostat in Resistant Hypertension first appeared on News Health.
Author : News Health
Publish date : 2025-03-29 19:44:00
Copyright for syndicated content belongs to the linked Source.